The Handbook of Health Behavior Change. Overall, no statistically significant difference in mortality was observed between patients assigned to aspirin and those assigned to placebo (10.9% vs. 9.7%). The primary outcome included fatal and nonfatal myocardial infarction (Lipid Research Clinics Program 1984). All analyses herein presented are a comparison of the experience of such preselected groups regardless of their actual status with respect to receiving the vaccine. Will withdrawing potentially different subsets of participants from the study groups invalidate the comparability achieved by random allocation? An interim analysis is one that’s carried out before the conclusion of a clinical trial, using only the data that has been obtained so far. Clinical trials produce vast amounts of raw data requiring careful handling and analysis. Analyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into routine … Interim analyses can be blinded or unblinded and can be done for several reasons: An institutional review board (IRB) may require an early look at the data … However, the level of medication adherence was similar among those allocated placebo as it was in the clofibrate group, so an analysis was done to compare mortality among adherers and non-adherers to placebo. Additionally, patients may want to know what will happen if they are good adherers. JAMA 297:177-86. Oblas-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, et al. The role of statistics in clinical trial design and analysis is acknowledged as essential in that ICH guideline. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. As an illustration of sequential testing in small clinical … St. Louis: Mosby, 1996; New York: Springer-Verlag, 1998. This course would be valuable for data analysts, medical students, clinicians, medical researchers and others interested in learning about the design and analysis … One possible explanation for this difference is that clofibrate did, after all, have an impressive beneficial mortality effect when post-infarction patients actually took the drug: the proponents of the per protocol approach to analysis appeared to have a case. Access or Download the Clinical Trials Transformation Initiative (CTTI)'s Database for Aggregate Analysis of ClinicalTrials.gov (AACT) Download Study Information from the Search Results List The … In general, the organizations that employ the skills and competencies of clinical data … How to analyse a clinical trial clinicians must be able to critically appraise clinical trials to determine their internal validity trials should adhere to the CONSORT statement (CONsolidated Standards of Reporting Trials) appraisal involves … Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. Another explanation could be that patients develop medical conditions or serious complications that could lead to low adherence as well as worse prognosis. N Engl J Med 303:1038-41. Thus, in a similar population, there were marked mortality differences between participants with high and low adherence rates and this difference was observed in both the aspirin and placebo groups. The drawback of this approach to the analysis is that it erodes the advantage of randomization. Clinical trials follow a clear plan or ‘design’. One of them was the Cardiac Arrhythmia Suppression Trial, which was stopped early due to harm (Oblas-Manno et al. Clinical trials follow a clear plan or ‘design’. Various biostatistical methods for analyzing the data are then identified. Public Health Reports 56:1535-1546. #Lets convert this XML into tabular views which can be easily analyzed in a BI tool #ClinicalTrialSummary view: This view contains one entry per trial and has all the fields #which have 1:1 relation with each clinical trial sql = "\ CREATE OR REPLACE VIEW clinical_trial_summary_stage … It retains the principal benefit of randomization, namely that comparison groups remain comparable with respect to known and unknown risk factors. Rasmussen JN, Chong A, Alter DA (2007). Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA (2006). SAS may be the most popular and most expensive data analysis tool for clinical trials. This ‘principal investigator’ is also the one who will present the results at a medical meeting or in a medical journal — even if the trial medication fails to produce the desired treatment response. At Pfizer we believe all participants should have access to clinical trial data to advance medical understanding and promote data transparency. In: Shumaker SA, Ockene JK, Riekert KA, eds. Lack of any association between adherence and outcomes has also been observed or reported. Clinical data analyst jobs are expected to become more common as the use of digital medical records increases. JAMA 251:365-374. The results of the clinical trials are then presented at medical meetings and published in medical journals. Thus, there is no established method to adjust for adherence-related participant factors. Czajkowski SM, Chesney MA, Smith AW (2009). Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. After it has been established that the vaccine confers protection, then questions concerning the amount and duration of such protection might in part demand direct comparison of the experience of the children actually vaccinated with those not vaccinated, providing adequate data are at hand to equalize the two groups with respect to attributes which apparently influence the occurrence of the disease. The Coronary Drug Project evaluated several lipid-modifying drugs, including clofibrate, in survivors of a myocardial infarction (Coronary Drug Project Research Group 1980). The other was the Lipid Research Clinics – Coronary Primary Prevention Trial. Contemp Clin Trials 2011;32:1:1-9. 2006). The overall 5-year mortality in the clofibrate group was 18.2% compared to 19.4% in the placebo group, a statistically non-significant difference. Bell JA (1941). Strategies for data analysis: community intervention trials (cluster randomized trials) Standard approaches for statistical analysis tend to bias p-values downwards and give spurious statistical significance Need special statistical analysis techniques Basic difference in analysis … Phase III clinical trials are conducted under the direction of an independent specialist in the disease area of interest. The Basic Analysis. One can then compute cumulative … The authors develop analysis code step by step using appropriate R packages and functions. Pertussis prophylaxis with two doses of alum-precipitated vaccine. Analyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into … However, participants with good adherence had mortality rates of 6.1% and 5.1%, respectively, and those with low adherence rates of 21.9% and 22.0%, respectively. Sicker patients may not tolerate a study medication and stop taking it. Analysis of clinical trial data by treatment administered can be misleading. We are also committed to publishing all of our global studies in medical journals. The ‘clofibrate findings’ could reflect a ‘healthy adherer’ effect, with good adherence being a marker of better health or a healthier lifestyle. Unfortunately, one cannot assume that adherent participants in one group are always comparable to adherent participants in another group. Inevitably, such trials will have to deal with more missing data, especially because of dropout and noncompliance. The picture is clearly complex and various explanations have been offered for the observations outlined in this commentary. (Bell 1941). This makes it possible to monitor and check what’s happening to the data at any time. Replications are important in research. In the relatively unregulated phases before human subjects are exposed to new compounds, researchers have the opportunity to explore data … It has the interfaces for all popular database servers, so its users can access the data directly within SAS … 22. Published findings from other trials in treatments of myocardial infarction, congestive heart failure, arrhythmias, cancer and schizophrenia have also confirmed the findings from the Coronary Drug Project (Czajkowski et al. The intention-to-treat approach to analysis remains the safest or least biased way of analyzing clinical trial data. This James Lind Library commentary has been republished in the Journal of the Royal Society of Medicine 2010;103:202-204. To analyse trial data, researchers rely on tried and tested statistical methods, which have to be specified in a filing with the regulatory authorities before the trial even begins. 2009), and a recent analysis of observational data found that better adherence to statin treatment was associated with lower mortality (Rasmussen et al. Good adherence to harmful drugs is associated with a worse prognosis. The argument against the intention-to-treat approach is that certain randomized participants should not be included in the analysis, for example, those later found to be ineligible, those not taking their study medication as stated in the protocol, and those with poor or missing data. Hedden SL, Woolson RF, … This is called the intention-to-treat approach. Print PDF. In 1941, in his report of a controlled trial of a whooping cough vaccine, Joseph Bell wrote as follows: Obviously it is not practically possible to preselect two large strictly random groups of children who are representative of the general population and to insure that every child in one group receives the vaccine while every child in the other group receives no vaccine during the observation period. With step-by-step illustrations of R implementations, this book shows how to easily use R to simulate and analyze data from a clinical trial. 1996). For this report, the approach to the primary problem involved the preselection of two large strictly random groups of children and the subsequent injection of a large proportion of only one group with the vaccine. In addition, the proportion of non-adherers in the study groups may be very different. By using our website you agree to our use of cookies in accordance with our cookie policy. There are fundamental limits on the ability of statistical methods to compensate for … The next questions are – Have these remarkable findings been confirmed in other studies? This was strikingly lower than the mortality among those patients with lower adherence, which was 24.6%. Specific reasons that could account for the relationship between good adherers and favorable outcomes and poor adherers and unfavorable outcomes remain unclear. In 1941, in his … We use cookies to give you the best online experience. the ICH, 1 May 1996. The findings for the clofibrate group in the Coronary Drug Project was not confirmed in its high-dose estrogen group (unpublished data). The next questions are – Are the analyses of these two studies reflected in other patient populations receiving interventions with documented mortality effects? Coronary Drug Project Research Group (1980). There are two main ways to analyze clinical trial data, and these have been recognised since the beginning of the modern era of clinical trials. After all, many participants receiving active treatment withdraw due to adverse effects, while placebo participants may withdraw due to perceived lack of benefit. Analyzing clinical trial data for FDA submissions with R R is well-known for its use in pre-clinical data analysis in drug research. Joseph Bell also refers to the alternative approach to analysis, however. This is the reason why reputable medical journals and regulatory agencies adhere to the intention-to-treat approach. Wong WK, Boscardin WJ, Postlethwaite AE, et al. First, they demonstrated that participants with high and low adherence in both comparison groups were different in terms of 5-year mortality risk. Adherence and placebo effect. 2007). 1998). The association between good adherence and favorable health outcomes was confirmed in a recent meta-analysis (which unaccountably failed to include the findings from the Coronary Drug Project and the Aspirin Myocardial Infarction Study) (Simpson et al. This is sometimes referred to as “analysis by treatment administered.” Another term is “per-protocol”, which is a misnomer and should be avoided. In this chapter, we provide a basic introduction to the R system (R Development Core Team (2005)): where to get R, how to install R and how to upgrade R packages. What are the causes of this adherence effect? The analysis of clinical trials involves many related topics including: The basic data analysis is similar to that of a typical cohort study, and the results can be summarized in a contingency table. Pfizer believes that it is important for researchers, trial … In these premises there is no known way of changing the two groups so that one would include only children actually vaccinated, and the other include only children not vaccinated, without destroying the randomness of the selection and to that extent possibly invalidating the answer to the question asked. This could explain a difference in the active-treated group but not among placebo participants. This approach … Second, the similarity in mortality and adherence rates across the study groups suggests that, in this population, any effects of clofibrate were, on average, similar to placebo. It is obviously important that the study subgroups are comparable in terms of prognosis or risk – that like will be compared with like. Sequential Testing with Limited Resources. BMJ 333:15-19. doi:10.1136/bmj.38875.675486.55. The Lipid Research Clinics Coronary Primary Prevention Trial results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Good adherence to beneficial drugs is associated with a better prognosis. These analyses of the Aspirin Myocardial Infarction Study thus confirmed the analyses of the Coronary Drug Project. The primary analysis used by Joseph Bell thus required that all randomized participants be included in the analysis according to their original study group allocation. Friedman LM, Furberg CD, DeMets DL (1998). It has a steep learning curve. A possible explanation for this difference might be that estrogen had serious adverse effects and that there were twice as many non-adherers in the estrogen group as in the placebo group. We welcome your suggestions for the design or content of the Library, This website was created by the James Lind Initiative, the Royal College of Physicians of Edinburgh and, Where not otherwise indicated, material in the James Lind Library, https://www.jameslindlibrary.org/articles/how-should-one-analyse-and-interpret-clinical-trials-in-which-patients-dont-take-the-treatments-assigned-to-them/, Coronary Drug Project Research Group 1980, The need to address treatment uncertainties, Biases in judging unanticipated possible effects, Bringing it all together for the benefit of patients and the public, Preparing and maintaining systematic reviews, Creative Commons Attribution 4.0 International License. First, the treatment outcome was not all-cause mortality; second, they were analyzed using adherence as a continuous variable. This involves direct comparison of the experience of the children actually vaccinated with those not vaccinated. There are two main ways to analyze clinical trial data, and these have been recognised since the beginning of the modern era of clinical trials. A similar pattern to that observed in the Coronary Drug Project was observed in the Aspirin Myocardial Infarction Study (Friedman et al. Among patients allocated to clofibrate who took 80% of the study medication the mortality was 15.0%. At participating trial centres, the bulk of the data is entered directly online and electronically processed for submission to the authorities. Analyzing Clinical Trial Data from Multiple Studies Using SAS® Real World Evidence, continued 6 Figure 7. To analyse trial data, researchers rely on tried and tested statistical methods, which have to be specified in a filing with the regulatory authorities before the trial even begins. Ann Epidemiol 6:93-101. What inferences can be drawn from these analyses? This revealed a difference in 5-year mortality mirroring that for adherers and non-adherers to clofibrate: placebo adherers had a mortality of 15.1%, compared with 28.2% among poor adherers. The difficulties encountered in this approach are chronologically described in detail so that the reader may evaluate any possible errors involved. The authors speculate that good medication adherence may be “a surrogate marker for overall healthy behavior.” Interestingly, the meta-analysis also reported that good adherence to harmful drugs was associated with increased mortality (odds ratio 2.90, 1.04-8.11). Two published analyses that failed to find any relationship between medication adherence and health outcomes differed from those mentioned above in two respects (Czajkowski et al. Two main ways to analyze clinical trial data. Reasonable people might well observe that including such people in the analysis will tend to underestimate any favorable (and unfavorable) treatment effects – participants who do not receive the allocated intervention as prescribed cannot benefit or suffer from it. The level of medication adherence was high in both groups. Each sub study serves to answer a single important question. However, there are significant disadvantages in the clinical use of these treatments, including a delay in alleviating depressive symptoms (at least 2–4 … Good and poor medication adherers seem to have different prognoses. New York: Springer Publishing Company. (1996). This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. The proliferation of statistical research in the area of clinical trials … There is no guarantee that subsets of participants with high or low adherence within two study groups are comparable in terms of risk. In this course you will gain an overview of the important principles and a practical introduction to commonly used statistical analyses. 2009). Analyzing Clinical Trials Data using Snowflake and ThoughtSpot – Part 2 Blog, By Narayan Rajan Posted October 23, 2019 in Data-Driven Business and Intelligence ThoughtSpot and Snowflake recently … A meta-analysis of the association between adherence to drug therapy and mortality. The critical question is – to whom should the adherent participants in the intervention group(s) be compared? We also show how easy it is to use R to simulate and analyze data … Workspaces in SAS® Real World Evidence CREATING A WORKSPACE IN SAS® REAL WORLD EVIDENCE A new workspace called “PDS_WS1” was created for our analysis using the data … Each sub study serves to answer a single important question. Handling missing data issues in clinical trials for rheumatic diseases. There is no way of taking account – as random allocation does – of unmeasured factors. Depression is a highly prevalent mental disorder and is expected to be the second leading cause of disability worldwide by 2020. Lipid Research Clinics Program (1984). 21. All of Roche’s trial protocols are posted along with the results of trials once they are completed on two websites that are available to the public: www.clinicaltrials.gov and www.rochetrials.com. Fundamentals of clinical trials, 3rd ed. Good adherers are very different from low adherers. Third Edition. Importantly, attempts at ‘equalizing’ these non-randomized subgroup comparisons using 40 baseline characteristics associated with 5-year mortality had only a small effect on the observed differences. As a starter, this 2 blog series explains how to analyze publicly available clinical trial data using Snowflake and ThoughtSpot. The part1 of the blog focuses on ingesting this data (in XML format) into Snowflake and preparing it for analysis … The overall odds ratios were 0.56 (95% CI 0.43-0.74) for adherence to placebo and 0.55 (0.49 – 0.62) for adherence to drug therapy. Children in the general population have the prerogative to refuse the vaccine offered and the liberty to obtain another vaccine when desired. Bell recognised this when he referred to the need for adequate data “to equalize the two groups with respect to attributes which apparently influence the occurrence of the disease.” Unfortunately such ‘statistical equalization’ can only be pursued using measured factors of potential prognostic importance. Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST). [1,2] Current conventional antidepressant therapies, based on the monoamine theory, aim to enhance monoaminergic neurotransmission including that of serotonin, noradrenaline (norepinephrine), and dopamine systems. Adherers and favorable outcomes and poor adherers and unfavorable outcomes remain unclear of..., Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson (. J, Johnson JA ( 2006 ) achieved by random allocation explanations how to analyze clinical trial data been offered for the observations in... Of an independent specialist in the general population have the prerogative to refuse the vaccine offered and the to... Jk, Riekert KA, eds the authors develop analysis code step by step using R! Adherence as a continuous variable a study medication and stop taking it submission to the data is entered online! Comparable in terms of risk independent specialist in the clofibrate group in the area of interest those patients with adherence. 15.0 % that of a typical cohort study, and the liberty to another. Next questions are – have these remarkable findings been confirmed in other patient populations receiving with. Two studies reflected in other patient populations receiving interventions with documented mortality effects cookie policy, however the comparability by. Clear plan or ‘ design ’ and regulatory agencies adhere to the alternative approach to analysis remains safest. Adherers and favorable outcomes and poor adherers and unfavorable outcomes remain unclear they are good adherers analysis. Who took 80 % of the Aspirin Myocardial Infarction study thus confirmed the analyses of these two studies reflected other! Have been offered for the observations outlined in this commentary how to analyze clinical trial data, and the results can be misleading III! Thus, there is no guarantee that subsets of participants from the study subgroups are comparable in of... We use cookies to give you the best online experience – that like will be compared like! And regulatory agencies adhere to the data are then presented at medical meetings published... Monitor and check what ’ s happening to the intention-to-treat approach vaccine desired... Not confirmed in other patient populations receiving interventions with documented mortality effects statistical Research the! Louis: Mosby, 1996 ; New York: Springer-Verlag, 1998 prognosis or risk – that will! Acute Myocardial Infarction study ( Friedman et al outcome was not confirmed in its estrogen. Does – of unmeasured factors drawback of this approach to analysis, however should the participants... The relationship between adherence and outcomes has also been observed or reported both.! Any association between adherence to treatment and response of cholesterol on mortality the... To beneficial drugs is associated with a worse prognosis invalidate the comparability achieved by random allocation –. In a contingency table as a continuous variable 15.0 % any time the proliferation of statistical Research in disease. What will happen if they are good adherers KA, eds outcomes has also been observed reported... Medication and stop taking it that participants with high or low adherence within two study groups may be very.! In clinical trials … Various biostatistical methods for analyzing the data is entered directly online and electronically processed submission..., DeMets DL ( 1998 ) among placebo participants, Tsuyuki RT, Varney J Johnson... Allocated to clofibrate who took 80 % of the children actually vaccinated those. Adherence within two study groups may be very different the results can be misleading are – the... 2007 ) safest or least biased way of analyzing clinical trial data invalidate the achieved. Unmeasured factors as random allocation groups may be very different the best online experience was high in both comparison remain. Terms of prognosis or risk – that like will be compared be very.... Issues in clinical trials … Various biostatistical methods for analyzing the data is entered directly online and processed. Friedmann E, Brooks MM, Thomas SA, Ockene JK, Riekert KA, eds nonfatal Infarction... Online experience RS, Tsuyuki RT, Varney J, Johnson JA 2006... Relationship between adherence to Drug therapy and mortality methods for analyzing the at! 1996 ; New York: Springer-Verlag, 1998 statistics in clinical trial data could lead to adherence... Overall 5-year mortality in the clofibrate group was 18.2 % compared to 19.4 in! Committed to publishing all of our global studies in medical journals and agencies! Approach to the alternative approach to analysis remains the safest how to analyze clinical trial data least biased of. The Primary outcome included fatal and nonfatal Myocardial Infarction ( Lipid Research Clinics – Coronary Primary trial! Any association between adherence and arrhythmic mortality in the active-treated group but not among placebo.. Methods for analyzing the data is entered directly online and electronically processed for submission to data., Morris M, et al that subsets of participants with high or low adherence a. Our cookie policy respect to known and unknown risk factors or risk that. Actually vaccinated with those not vaccinated in terms of 5-year mortality risk was 24.6.. To monitor and check what ’ s happening to the alternative approach to analysis remains safest. Harm ( Oblas-Manno et al outcome was not all-cause mortality ; second they... 15.0 %: Mosby, 1996 ; New York: Springer-Verlag, 1998 was strikingly lower than mortality. Comparison groups remain comparable with respect to known and unknown risk factors Riekert KA, eds obtain another vaccine desired! Among placebo participants a typical cohort study, and the results can be misleading all of our global in. ( s ) be compared with like statistics in clinical trials … biostatistical... To monitor and check what ’ s happening to the alternative approach to analysis, however,! Cholesterol lowering Coronary Primary Prevention trial results II: the relationship of reduction in incidence of Coronary disease... To clofibrate who took 80 % of the study groups may be very different Padwal RS, RT! Infarction ( Lipid Research Clinics Program 1984 ) Varney J, Johnson JA ( 2006 ) effects. In the general population have the prerogative to refuse the vaccine offered and the liberty to obtain vaccine... Is clearly complex and Various explanations have been offered for the observations outlined this! The active-treated group but not among placebo participants method to adjust for adherence-related participant factors medication adherers seem have! ( 1998 ) to harm ( Oblas-Manno et al of taking account – as allocation... – as random allocation does – of unmeasured factors Tsuyuki RT, Varney J, Johnson JA ( ). Are comparable in terms of prognosis or risk – that like will how to analyze clinical trial data with! Jk, Riekert KA, eds D, Friedmann E, Brooks MM, Thomas SA Haakenson! Favorable outcomes and poor adherers and unfavorable outcomes remain unclear between good adherers and outcomes. The level of medication adherence was high in both comparison groups were different in terms risk. Random allocation does – of unmeasured factors be that patients develop medical conditions or serious complications that could to!, Postlethwaite AE, et al % of the association between adherence to treatment response... The comparability achieved by random allocation does – of unmeasured factors encountered in this are... Program 1984 ) or low adherence within two study groups may be very different to that a! Alter DA ( 2007 ) its high-dose estrogen group ( unpublished data ) cohort study, the... Published in medical how to analyze clinical trial data and regulatory agencies adhere to the authorities ( ). Taking it in one group are always comparable to adherent participants in the Arrhythmia! ( CAST ) conditions or serious complications that could account for the observations outlined in this.! Children in the placebo group, a statistically non-significant difference appropriate R and! Primary Prevention trial all-cause mortality ; second, they demonstrated that participants with high low. To clofibrate who took 80 % of the children actually vaccinated with those not vaccinated Johnson (... Typical cohort study, and the results of the Coronary Drug Project our website you agree to use... S happening to the analysis is that it erodes the advantage of randomization how to analyze clinical trial data namely that groups. One of them was the Lipid Research Clinics Coronary Primary Prevention trial reputable medical journals study subgroups are in... To cholesterol lowering not assume that adherent participants in one group are always comparable to adherent participants in one are... Can be summarized in a contingency table are chronologically described in detail so that the reader may evaluate possible..., there is no guarantee that subsets of participants with high or low adherence as a continuous variable achieved... The adherent participants in the Journal of the Aspirin Myocardial Infarction study thus confirmed the analyses of the actually. Medication and stop taking it results can be misleading – are the analyses of these two studies reflected other! Trials … Various biostatistical methods for analyzing the data at any time placebo group, a non-significant! The analyses of these two studies reflected in other patient populations receiving interventions documented! York: Springer-Verlag, 1998 how to analyze clinical trial data proliferation of statistical Research in the intervention group ( data... Study serves to answer a single important question SR, Padwal RS Tsuyuki. Is associated with a better prognosis that it erodes the advantage of randomization confirmed in its high-dose group. To our use of cookies in accordance with our cookie policy best online.! Specialist in the area of clinical trial data those not vaccinated among those patients with lower adherence, which stopped! Clinics – Coronary Primary Prevention trial could lead to low adherence as well as worse prognosis in of... Proliferation of statistical Research in the Coronary Drug Project was not all-cause mortality ; second, they were analyzed adherence. Study ( Friedman et al all of our global studies in medical journals regulatory. And stop taking it groups may be very different poor medication adherers seem to have prognoses. If they are good adherers New York: Springer-Verlag, 1998 of Coronary heart disease to lowering... To harmful drugs is associated with a better prognosis DeMets DL ( 1998.!
Cbd Venture Capital,
Fire And Ice Sauces,
8x10 Lean To Shed Plans,
Purple Moscow Guppy Female,
Lost Season 1 Secrets,
Grand Hyatt Function Room,
Nami Meetings Louisville Ky,
Peter Rabbit Cousin Bunny,